Journal article

Amniotic fluid embolism: An Australian-New Zealand population-based study

N McDonnell, M Knight, MJ Peek, D Ellwood, CSE Homer, C McLintock, G Vaughan, W Pollock, Z Li, N Javid, E Sullivan

BMC Pregnancy and Childbirth | Published : 2015

Open access

Abstract

Background: Amniotic fluid embolism (AFE) is a major cause of direct maternal mortality in Australia and New Zealand. There has been no national population study of AFE in either country. The aim of this study was to estimate the incidence of amniotic fluid embolism in Australia and New Zealand and to describe risk factors, management, and perinatal outcomes. Methods: A population-based descriptive study using the Australasian Maternity Outcomes Surveillance System (AMOSS) carried out in 263 eligible sites (>50 births per year) covering an estimated 96% of women giving birth in Australia and all 24 New Zealand maternity units (100% of women giving birth in hospitals) between January 1 2010-D..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Health and Medical Research Council


Funding Acknowledgements

Funding for AMOSS was through the National Health & Medical Research Council (App ID 510298). In NZ AMOSS is supported and funded by the Perinatal and Maternal Mortality Review Committee. We acknowledge the support of participating maternity units and AMOSS data collectors in Australia and New Zealand who participated in the study. Dr Nolan McDonnell was supported by a WA Department of Health and Raine Medical Research Foundation Clinician Research Fellowship.